Vaxcyte, Inc. (PCVX)
44.08
-0.66
(-1.48%)
USD |
NASDAQ |
Dec 10, 11:07
Vaxcyte Shareholders Equity (Quarterly): 2.893B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 51.02B |
| Novavax, Inc. | -156.67M |
| Pfizer Inc. | 92.80B |
| Moderna, Inc. | 9.33B |
| Eli Lilly & Co. | 23.79B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.172B |
| Total Liabilities (Quarterly) | 278.72M |
| Debt to Equity Ratio | 0.0292 |
| Current Ratio | 8.834 |
| Net Debt Paydown Yield | -0.25% |